PL
DAWN

Parkwood LLC’s Day One Biopharmaceuticals DAWN Stock Holding History

Parkwood LLC’s Portfolio DAWN Stock Details DAWN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-275,000
Closed -$1.94M – 100
2025
Q3 		$1.94M Hold
275,000
– – 0.18% 77
2025
Q2 		$1.79M Hold
275,000
– – 0.16% 80
2025
Q1 		$2.18M Hold
275,000
– – 0.2% 78
2024
Q4 		$3.48M Buy
+275,000
New +$3.83M 0.4% 73
2023
Q2 		– Sell
-20,381
Closed -$272K – 149
2023
Q1 		$272K Buy
20,381
+1,028
+5% +$20.1K 0.04% 134
2022
Q4 		$416K Buy
19,353
+878
+5% +$18K 0.06% 116
2022
Q3 		$370K Buy
+18,475
New +$393K 0.06% 124

Other funds holding DAWN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $94.8B AUM 24.11% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Parkwood LLC's DAWN Position: Q4 2025 in Review

Parkwood LLC sold out of Day One Biopharmaceuticals (DAWN) in Q4 2025, closing a stake of 275,000 shares — an estimated $1.94M sold.

Parkwood LLC first reported a position in DAWN in Q3 2022 and held it in 7 quarters. The position peaked at $3.48M in Q4 2024. 183 funds tracked by Wall St. Rank hold DAWN as of Q4 2025.

  • Parkwood LLC reported no remaining Day One Biopharmaceuticals position as of Q4 2025 after selling out during the quarter.
  • Parkwood LLC sold 275,000 Day One Biopharmaceuticals shares in Q4 2025, an estimated $1.94M.
  • Parkwood LLC first reported a position in Day One Biopharmaceuticals in Q3 2022 and held it in 7 quarters.
  • Parkwood LLC's Day One Biopharmaceuticals position peaked at $3.48M in Q4 2024.
  • 183 funds tracked by Wall St. Rank held Day One Biopharmaceuticals as of Q4 2025.

Based on Parkwood LLC's 13F filing for Q4 2025, filed 17 Feb 2026.